Common Stock, Shares Authorized of Aligos Therapeutics, Inc. from 05 Feb 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Aligos Therapeutics, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 05 Feb 2018 to 31 Dec 2025.
  • Aligos Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending 31 Dec 2025 was 115,800,000, a 457% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Aligos Therapeutics, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 115,800,000 +95,000,000 +457% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 115,800,000 +95,000,000 +457% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 115,800,000 -404,200,000 -78% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 20,800,000 -299,200,000 -94% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 20,800,000 +8,000,000 +62% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 20,800,000 -299,200,000 -94% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 520,000,000 +200,000,000 +62% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 320,000,000 0 0% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 12,800,000 -307,200,000 -96% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 320,000,000 0 0% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 320,000,000 0 0% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 320,000,000 0 0% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 320,000,000 0 0% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 320,000,000 0 0% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 320,000,000 0 0% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 320,000,000 0 0% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 320,000,000 0 0% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 320,000,000 +42,000,000 +15% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 320,000,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 320,000,000 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 320,000,000 +42,000,000 +15% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 278,000,000 30 Sep 2020 10-Q 25 Nov 2020 2020 Q3
Q4 2019 278,000,000 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2018 149,000,000 15 Aug 2018 10-K 23 Mar 2021 2020 FY
Q2 2018 25,000,000 23 Jul 2018 10-K 23 Mar 2021 2020 FY
Q4 2017 20,000,000 05 Feb 2018 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.